Pancreatic Cancer Research

ResearcherStony Brook UniversityActive in the last 2 years

Agnieszka Beata Bialkowska

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2127-7714; OpenAlex author ID A5000994247; NIH RePORTER profile ID 10240077. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
1
Labs led
1
Collaborators
8
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper, 1 grant · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. AUM-302, a novel triple PIM/PI3K/mTOR inhibitor, synergizes with RAS inhibition and impedes the growth of pancreatic ductal adenocarcinoma spheroids and organo… Last author DOI 10.3389/fphar.2026.1685433↗
  2. AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor. Last author DOI 10.1371/journal.pone.0294065↗
  3. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia… Last author DOI 10.1053/j.gastro.2017.12.005↗

Grants 1

  1. Mechanisms of injury-induced pancreatic neoplasia R01DK124342↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Joseph F. LaComb · 2 shared papers, 2023–2026 · strength 0.53
  2. Antonio T. Baines · 2 shared papers, 2023–2026 · strength 0.53
  3. Emma Wen · 1 shared paper, 2026 · strength 0.29
  4. Fatim M. Kouassi · 1 shared paper, 2026 · strength 0.29
  5. David Arthur Tuveson · 1 shared paper, 2026 · strength 0.29
  6. Komala Ingle · 1 shared paper, 2023 · strength 0.24
  7. Lee M. Graves · 1 shared paper, 2023 · strength 0.24
  8. Ping He · 1 shared paper, 2018 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.